Results 161 to 170 of about 110,593 (299)
Summary A 4‐year‐old, 520 kg, American Quarter Horse broodmare, approximately 90 days in foal, was presented to Texas A&M University Teaching Hospital for suspected liver disease. Based on clinicopathological values and hepatic abnormalities noted ultrasonographically, the mare was presumptively diagnosed with cholangiohepatitis.
A. C. Trimble +6 more
wiley +1 more source
A bilateral stylohyoid fracture
Summary A 6‐year‐old Thoroughbred gelding (610 kg) was referred to the Ontario Veterinary College—Health Sciences Centre for evaluation of lethargy, acute upper airway noise and dysphagia. On presentation, the horse was quiet, alert and responsive.
A. Merchán +3 more
wiley +1 more source
Unspecific Peroxygenases-Catalyzed Oxidation of Pharmaceutical Compounds Considered Emerging Contaminants. [PDF]
Torres-Aguirre A +4 more
europepmc +1 more source
Impaired platelet activation in patients with hereditary deficiency of p47phox [PDF]
Azzari, Chiara +10 more
core +2 more sources
Otitis in pet guinea pigs: Causes, clinical signs, treatment and outcomes
Abstract Background Otitis is a major disease impacting both pet guinea pigs and laboratory guinea pigs that are used as models in human otological studies. Methods Medical records from two veterinary clinics were retrospectively reviewed to identify guinea pigs diagnosed with computed tomography (CT)‐confirmed otitis between 2014 and 2023.
Patricia Muffat‐es‐Jacques +5 more
wiley +1 more source
Design and implementation of Cs/GO/TiO<sub>2</sub> nanocomposite for controlling sulfamethoxazole. [PDF]
Amin KS +5 more
europepmc +1 more source
Micropollutants can act as molecular triggers that activate a newly designed and chemically inert Fenton‐like PKU‐24 catalyst for on‐demand singlet oxygen generation from peroxymonosulfate (PMS), enabling nearly complete peroxide utilization and selective micropollutant removal from complex real‐world wastewater.
Yu‐Hang Li +7 more
wiley +1 more source
Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia. [PDF]
Bur R +7 more
europepmc +1 more source
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett +20 more
wiley +1 more source
Intravenous trimethoprim-sulfamethoxazole desensitization as a therapeutic strategy for late-onset Pneumocystis jirovecii pneumonia in a kidney transplant recipient: a case report. [PDF]
Yılmaz B.
europepmc +1 more source

